Humana, Inc. (HUM) and Novo Nordisk A/S (NVO) Form Partnership to Improve Quality Outcomes for Patients Fighting Diabetes
6/18/2012 10:39:52 AM
LOUISVILLE, Ky. & PRINCETON, N.J.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) and Novo Nordisk Inc. (NYSE: NVO) today announced a one-year research partnership to explore diabetes treatment and care. Together, researchers will identify opportunities to change how patients might be treated to improve quality and outcomes for the millions of people who battle diabetes.
comments powered by